Zevra Therapeutics
ZVRA
#7323
Rank
A$0.78 B
Marketcap
A$13.23
Share price
-3.42%
Change (1 day)
-11.82%
Change (1 year)

EPS for Zevra Therapeutics (ZVRA)

EPS in 2026 (TTM): A$1.53

According to Zevra Therapeutics's latest financial reports the company's current EPS (TTM) is A$1.60. In 2016 the company made an earnings per share (EPS) of A-$29.25 an increase over its 2015 EPS that were of A-$102.86.

EPS history for Zevra Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.53
2016A-$29.25-71.57%
2015A-$102.86